Brief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
27/05/2026 07:50
BRIEF-Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25 May 27 (Reuters) - ASKA Pharmaceutical Holdings Co Ltd 4886.T:
DALTON INVESTMENT: STRONGLY OPPOSE CONDITIONAL ACTIVATION OF COUNTERMEASURES ANNOUNCED BY ASKA PHARMACEUTICAL HOLDINGS ON MAY 25
Source text: [ID:]
Further company coverage: 4886.T
Recent news on ASKA Pharmaceutical Holdings Co
See all newsBrief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
Brief: Aska Pharmaceutical -Plan To Put To Shareholders Proposal On Countermeasures Against Potential Large-Scale Share Purchase By Dalton And Related Parties
Table: Aska Pharmaceutical Holdings -2025/26 group results
Table: Aska Pharmaceutical Holdings -2025/26 group results
Insilico Medicine And Aska Pharmaceutical Expand Partnership To Discover Novel Targets For Women's Health